LUMEBLUE

This brand name is authorized in Austria, Croatia, Estonia, France, Ireland, Italy, Lithuania, Poland.

Active ingredients

The drug LUMEBLUE contains one active pharmaceutical ingredient (API):

1	Methylthioninium chloride UNII 8NAP7826UB - METHYLENE BLUE ANHYDROUS
	In vivo, in low concentration, methylthioninium chloride speeds up the conversion of methaemoglobin to haemoglobin. Methylthioninium chloride has been observed to stain tissues selectively.
	Read more about Methylthioninium chloride

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LUMEBLUE Prolonged-release tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V04CX	Other diagnostic agents	V Various → V04 Diagnostic agents → V04C Other diagnostic agents
Discover more medicines within V04CX

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1826209
FR	Base de données publique des médicaments	64311245
IT	Agenzia del Farmaco	048994014
LT	Valstybinė vaistų kontrolės tarnyba	1091039
PL	Rejestru Produktów Leczniczych	100440291